|
|
Volumn 27, Issue 4, 2009, Pages 644-646
|
|
Randomized, double-blind, placebo-controlled trial of epoetin alfa in men with castration-resistant prostate cancer and anemia
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PLACEBO;
RECOMBINANT ERYTHROPOIETIN;
ADULT;
AGED;
ANEMIA;
BLOOD TRANSFUSION;
CASTRATION;
CENTRAL NERVOUS SYSTEM METASTASIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG DOSE INCREASE;
DRUG EFFECT;
DRUG SAFETY;
HEMOGLOBIN BLOOD LEVEL;
HEMOLYSIS;
HUMAN;
HYPERTENSION;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROSTATE ADENOCARCINOMA;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
ADENOCARCINOMA;
AGED;
AGED, 80 AND OVER;
ANEMIA;
CASTRATION;
DOUBLE-BLIND METHOD;
EPOETIN ALFA;
HEMATINICS;
HUMANS;
MALE;
MIDDLE AGED;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
VENOUS THROMBOEMBOLISM;
|
|
EID: 59149083000
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2008.20.4966 Document Type: Letter |
|
Times cited : (10)
|
|
References (4)
|
